Advertisement
Canada markets closed

  • S&P/TSX

    21,807.37
    +98.93 (+0.46%)
     

  • S&P 500

    4,967.23
    -43.89 (-0.88%)
     

  • DOW

    37,986.40
    +211.02 (+0.56%)
     

  • CAD/USD

    0.7275
    +0.0012 (+0.16%)
     

  • CRUDE OIL

    83.24
    +0.51 (+0.62%)
     

  • Bitcoin CAD

    87,811.25
    +456.74 (+0.52%)
     

  • CMC Crypto 200

    1,373.02
    +60.40 (+4.60%)
     

  • GOLD FUTURES

    2,406.70
    +8.70 (+0.36%)
     

  • RUSSELL 2000

    1,947.66
    +4.70 (+0.24%)
     

  • 10-Yr Bond

    4.6150
    -0.0320 (-0.69%)
     

  • NASDAQ

    15,282.01
    -319.49 (-2.05%)
     

  • VOLATILITY

    18.71
    +0.71 (+3.94%)
     

  • FTSE

    7,895.85
    +18.80 (+0.24%)
     

  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     

  • CAD/EUR

    0.6824
    +0.0003 (+0.04%)
     

Company News for Aug 28, 2020

Zacks Equity Research
·1 min read

  • Shares of Box, Inc. BOX rose 4.9% after the company reported fiscal second-quarter 2021 earnings per share of 18 cents, which surpassed the Zacks Consensus Estimate by 5 cents.

  • Shares of NetApp, Inc. NTAP jumped 4% after the company reported first-quarter fiscal 2021 earnings of 73 cents per share, beating the Zacks Consensus Estimate of 40 cents.

  • Shares of Abercrombie & Fitch Co. ANF surged 8.1% after the company reported second-quarter earnings of 23 cents per share, beating the Zacks Consensus Estimate of a loss of 89 cents.

  • Shares of Abbott Laboratories ABT surged 7.9% after the company reported that it has won U.S. approval to market a portable and rapid COVID-19 antigen test.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Abercrombie Fitch Company (ANF) : Free Stock Analysis Report
 
Abbott Laboratories (ABT) : Free Stock Analysis Report
 
NetApp, Inc. (NTAP) : Free Stock Analysis Report
 
Box, Inc. (BOX) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research